Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

zerohedge.com - Tyler Durden - 7 Federal Agencies & Big Pharma Quietly Built A Pandemic-Industrial Complex
7 Federal Agencies & Big Pharma Quietly Built A Pandemic-Industrial Complex
Zero Hedge

Nearly 14 years before COVID-19, HHS created the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) and centralized federal health, biomedical, regulatory, homeland-security, and military functions around a government-directed…

thestandard.com.hk - The Standard 英文虎報 - HSI rose 291 points by midday as pharma and commodity shares rally, Kuaishou fell 9.74pc
HSI rose 291 points by midday as pharma and commodity shares rally, Kuaishou fell 9.74pc
The Standard

Hong Kong stocks sustained their upward momentum at noon on Thursday as biopharmaceutical and commodity shares gained further. SCROLL TO CONTINUE WITH CONTENT The benchmark Hang Seng Index rose 291 points, or 1.14 percent, to 25,786 points…

newswire.ca - Aurora Cannabis Inc. - Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
CNW

EDMONTON, AB, Aug. 19, 2026 /CNW/ -- Aurora Cannabis Inc. (the 'Company' or 'Aurora') (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that it has acquired Internode Pharma Limited, a…

fool.com - Erin Kennedy - Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?
The Motley Fool

The Invesco Pharmaceuticals ETF (PJP +1.38%) offers concentrated exposure to U.S. drugmakers, while the Invesco Nasdaq Biotechnology ETF (IBBQ +0.93%) provides a broader, lower-cost gateway to the biotechnology and pharmaceutical sectors. Both…

thehindu.com - The Hindu Bureau - Pendurthi MLA seeks rehabilitation of Thadi village at the earliest
Pendurthi MLA seeks rehabilitation of Thadi village at the earliest
The Hindu

Pendurthi MLA Panchakarla Ramesh Babu has urged the State government to take immediate steps to rehabilitate and relocate residents of Thadi village in Anakapalli district, citing safety concerns due to several pharmaceutical units in and around…

jeffereyjaxen.substack.com - Jefferey Jaxen - Is Big Pharma Already Stalling Trump's Vaccine Executive Order?
Is Big Pharma Already Stalling Trump's Vaccine Executive Order?
Jefferey Jaxen on Substack

The term is called running the clock…stalling….buying time. Splitting the measles, mumps, rubella (MMR) vaccine into separate [monovalent] shots could now take 10 years according to mainstream reporting. A decade to make a presumably…

boredpanda.com - Viktorija Strelciunaite - 79 Random Bits Of Insider Knowledge From Different Industries To Change How You See The World
79 Random Bits Of Insider Knowledge From Different Industries To Change How You See The World
Bored Panda

Early childhood educators know everything about you and all your family members. EVERYTHING! I'm a retired Medical Lab Tech II from the Infusion Center at one of the largest hospitals in the country, and I learned that the human body's immune…

afaqs.com - afaqs! news bureau - SocioClout appoints Niyati Desai as AVP- growth
SocioClout appoints Niyati Desai as AVP- growth
afaqs!

Niyati Desai has joined integrated marketing agency SocioClout as associate vice president- growth. She will lead the agency's Mumbai business. Announcing her new role on LinkedIn, Desai said: “I'm excited to share that I'm joining…

techcrunch.com - Tim Fernholz - AI isn't close to curing cancer. This startup says it knows what it will take.
AI isn't close to curing cancer. This startup says it knows what it will take.
TechCrunch

A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem, and that it has built a machine to fix it. HIVE, modular robotic labs built by the company, can grow 20 kinds of human tissue, then autonomously dose and…

seekingalpha.com - High Alpha Professor - Travere Therapeutics: Valuation Suggests A Buy (NASDAQ:TVTX)
Travere Therapeutics: Valuation Suggests A Buy (NASDAQ:TVTX)
Seeking Alpha

Travere Therapeutics is rated Buy, with a DCF-based fair value of ~$81 per share, implying 27% upside. FILSPARI's commercial ramp is strong, posting $141.1M in Q2 U.S. sales and targeting a $3B+ peak sales opportunity across IgAN and FSGS. My model…

cnbc.com - Jeff Marks - We're booking a five-fold profit on one of drug stock's rally to record highs
We're booking a five-fold profit on one of drug stock's rally to record highs
CNBC

We're selling 10 shares of Eli Lilly at roughly $1,269 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will own 80 shares of LLY, decreasing its weighting in the portfolio to 2.6% from 2.9%. We're locking in big gains in pharma…

rediff.com - Nandita Malik - Nifty, Sensex Decline as Elevated Crude Oil Prices and US-Iran Tensions Unnerve Investors
Nifty, Sensex Decline as Elevated Crude Oil Prices and US-Iran Tensions Unnerve Investors
Rediff.com

Indian benchmark equity indices, Sensex and Nifty, experienced significant declines, with the Nifty extending its losing streak to a seventh day, as elevated crude oil prices and geopolitical tensions between the US and Iran unnerved investors. The…

cnbc.com - Morgan Chittum - Wall Street analysts just called this healthcare stock a buy - here's our take
Wall Street analysts just called this healthcare stock a buy - here's our take
CNBC

Every weekday, the CNBC Investing Club with Jim Cramer holds a 'Morning Meeting' livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. 1. Stocks rose Wednesday, supported by a decline in bond yields after the Treasury said it will…

fool.com - Motley Fool Transcribing - MaxCyte (MXCT) Q2 2026 Earnings Call Transcript
MaxCyte (MXCT) Q2 2026 Earnings Call Transcript
The Motley Fool

Wednesday, Aug. 12, 2026 at 4:30 p.m. ET President and Chief Executive Officer-Maher Masoud Chief Financial Officer-Parmeet Ahuja Senior Director of Business Development-Sean Menarguez Investor Relations-Erik Abdo Total Revenue -- $7.3 million…

247wallst.com - Vandita Jadeja - Stock Forecast: The Market is Sleeping on Eli Lilly's Next $1 Trillion Opportunity
Stock Forecast: The Market is Sleeping on Eli Lilly's Next $1 Trillion Opportunity
24/7 Wall St

Eli Lilly (NYSE:LLY | LLY Price Prediction) has quietly transformed itself into the first pharmaceutical company ever valued above $1 trillion, and yet the market may still be underpricing what comes next. Retatrutide, orforglipron, and a stacked…

Receive a Daily briefing on Pharma Industry News

Get Started